PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: VM Discovery, Inc. (VMD)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery - VM Discovery, Inc. (VMD), a drug-design and discovery company, and Fred Hutchinson Cancer Research Center today announced they have entered into a collaboration to jointly pursue a cancer-drug discovery program
VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery

 

NewswireToday - /newswire/ - Fremont, CA, United States, 2006/03/29 - VM Discovery, Inc. (VMD), a drug-design and discovery company, and Fred Hutchinson Cancer Research Center today announced they have entered into a collaboration to jointly pursue a cancer-drug discovery program.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery; Collaboration Focuses on Compounds Against an Important Cancer Pathway.

VM Discovery Inc. (VMD), a drug-design and discovery company, and Fred Hutchinson Cancer Research Center today announced they have entered into a collaboration to jointly pursue a cancer-drug discovery program. Under the collaboration, VMDI will use its proprietary multi-property drug design and optimization technology platform, the “VM OptimizerTM, to generate and optimize small-molecule ”drug-like” leads and clinical candidates, while the Hutchinson Center will leverage its expertise in cancer biology and proprietary technologies. Other terms of the collaboration were not disclosed.

“It is exciting to collaborate with the distinguished scientists and professionals at the Hutchinson Center to translate their strong and unique cancer-biology knowledge to the drug-able molecules for the potential breakthrough treatment of cancers,” said Jay Wu, president and CEO of VM Discovery Inc. “Having a successful track record with our industry clients, academic research institutes and our internal drug-discovery programs, we are confident that our proprietary technology platform will allow us to design and optimize advanced small-molecule drug candidates against an important cancer pathway .“

This is the Hutchinson Center’s first collaboration with the chemistry industry this year. “We are excited about this collaboration,” said Spencer Lemons, vice president of Industry Relations and Technology Transfer at the Hutchinson Center. “Bringing together our world-class research with the drug-discovery expertise of industry helps in our mission to eliminate cancer as a cause of human suffering and death.”

About VM Discovery Inc. (VMD)
VM Discovery Inc. (vmdiscovery.com) is a privately held, venture-backed drug discovery company located in Silicon Valley, California. The company has developed proprietary drug design and optimization technology “the “VM Optimizer™”) to discover novel, potent small-molecule drug leads with balanced ADMET (absorption, distribution, metabolism, elimination and toxicity) properties in various therapeutic arenas. VMD has been developing a portfolio of optimized preclinical drug candidates, including new uses of old drugs, in various disease areas including cancer, diabetes and neurological diseases. In addition, VMD has been a source of optimized molecules to drug development companies for out-licensing, sale or “compound partnering” purposes. VMD has ongoing drug discovery collaboration with biotechnology and pharmaceutical companies as well as prominent academic/research institutes.

About Fred Hutchinson Cancer Research Center
The Hutchinson Center’s interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Center researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: VM Discovery, Inc. (VMD)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jay Wu - VMDiscovery.com 
510-360-7224 info[.]vmdiscovery.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any VM Discovery, Inc. (VMD) securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From VM Discovery, Inc. (VMD) / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)